| Identification | Back Directory | [Name]
L-Cysteine, glycyl-L-prolyl-L-lysyl-L-threonyl-L-prolyl-L-α-glutamyl-L-α-glutamyl-L-lysyl-L-threonyl-L-alanyl-L-asparaginyl-L-threonyl-L-isoleucyl-L-seryl-L-lysyl-L-phenylalanyl-L-α-aspartyl- | [CAS]
309247-50-5 | [Synonyms]
L-Cysteine, glycyl-L-prolyl-L-lysyl-L-threonyl-L-prolyl-L-α-glutamyl-L-α-glutamyl-L-lysyl-L-threonyl-L-alanyl-L-asparaginyl-L-threonyl-L-isoleucyl-L-seryl-L-lysyl-L-phenylalanyl-L-α-aspartyl- | [Molecular Formula]
C84H136N22O30S | [MOL File]
309247-50-5.mol | [Molecular Weight]
1966.2 |
| Hazard Information | Back Directory | [Uses]
Protein Kinase C (beta) Peptide is a peptide fragment of Protein Kinase Cβ. Protein Kinase Cβ is related with hyperglycemia decreases endothelium-derived nitric oxide. Inhibition of Protein kinase Cβ prevents the reduction in endothelium-dependent vasodilation induced by acute hyperglycemia[1]. | [References]
[1] Beckman JA, et al. Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res. 2002;90(1):107-111. DOI:10.1161/hh0102.102359 |
|
|